background
human
coronavirus
hcov
caus
upper
lower
respiratori
tract
infect
hcov
global
distribut
predomin
speci
may
vari
region
year
prior
studi
shown
season
pattern
hcov
speci
annual
variat
speci
preval
nation
circul
pattern
us
yet
describ
object
describ
circul
pattern
hcov
us
studi
design
review
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
test
result
human
coronavirus
hcov
circul
worldwid
caus
rang
respiratori
symptom
infect
often
asymptomat
associ
mild
moder
upper
respiratori
tract
ill
immunocompet
children
adult
hcov
consid
second
common
caus
common
cold
infect
also
result
lower
respiratori
tract
ill
includ
bronchiol
pneumonia
especi
immunocompromis
individu
infant
older
adult
increas
avail
molecular
test
method
frequent
test
multipl
respiratori
pathogen
allow
opportun
character
circul
pattern
individu
hcov
although
hcov
global
distribut
predomin
speci
may
vari
region
year
previou
studi
shown
season
pattern
hcov
speci
annual
variat
speci
preval
howev
nation
circul
pattern
across
unit
state
describ
studi
describ
circul
four
hcov
across
multipl
year
object
describ
laboratori
detect
hcov
unit
state
use
data
collect
nation
respiratori
enter
viru
surveil
system
nrevss
nrevss
passiv
surveil
network
establish
us
center
diseas
control
prevent
cdc
collect
specimen
test
result
sever
respiratori
enter
virus
multipl
laboratori
across
unit
state
nrevss
current
collect
data
three
differ
sourc
directli
clinic
state
local
laboratori
indirectli
state
local
partner
behalf
laboratori
within
jurisdict
indirectli
public
health
laboratori
interoper
project
phlip
phlip
collabor
partnership
cdc
state
local
public
health
lab
phl
associ
public
health
laboratori
aphl
strengthen
submiss
autom
specimenlevel
surveil
laboratori
test
result
directli
cdc
laboratori
submit
nrevss
via
phlip
submit
specimen
level
result
respiratori
viru
test
along
patient
demograph
sex
age
remain
major
nrevss
particip
ie
nonphlip
submitt
submit
weekli
aggreg
posit
detect
four
hcov
speci
rtpcr
along
aggreg
number
rtpcr
hcov
test
perform
better
understand
hcov
circul
us
assess
report
specimen
test
hcov
submit
nrevss
juli
report
laboratori
exclud
report
hcov
result
speci
level
summar
total
number
hcov
test
submit
studi
period
calcul
overal
percent
posit
hcov
speci
week
test
number
posit
hcov
result
also
summar
separ
individu
us
censu
region
understand
demograph
patient
hcov
detect
analyz
subset
nrevss
data
report
phlip
select
report
specimen
test
four
hcov
speci
calcul
percent
posit
hcov
speci
use
phlip
report
singl
posit
hcov
detect
test
differ
age
distribut
among
four
hcov
speci
use
kruskal
walli
test
differ
sex
distribut
among
four
hcov
speci
test
use
chi
squar
test
summar
viral
codetect
hcov
speci
use
report
specimen
test
four
hcov
also
test
follow
virus
parainfluenza
virus
respiratori
syncyti
viru
rsv
human
metapneumoviru
human
adenoviru
rhinovirusenteroviru
influenza
influenza
b
analysi
perform
use
r
version
juli
hcov
test
report
laboratori
state
submit
nrevss
overal
posit
number
hcov
test
submit
nrevss
per
week
vari
season
test
peak
occur
year
winter
gener
decemb
march
fig
overal
hcov
test
increas
three
year
fig
percent
hcov
posit
test
vari
throughout
year
also
peak
year
decemb
march
percent
posit
vari
annual
hcov
speci
fig
demonstr
distinct
peak
three
year
less
pronounc
peak
demonstr
similar
pattern
one
anoth
small
peak
larger
peak
although
small
peak
show
slight
peak
peak
rel
larg
peak
fig
highest
percent
posit
singl
speci
test
posit
week
begin
decemb
across
censu
region
minim
differ
season
annual
pattern
percentag
test
posit
hcov
speci
seen
compar
nation
data
fig
notabl
differ
percentag
posit
test
season
west
region
show
peak
percent
posit
midwest
region
show
peak
percent
posit
data
report
nrevss
phlip
analyz
understand
sex
age
characterist
studi
period
specimen
test
four
hcov
submit
via
phlip
six
laboratori
overal
test
posit
hcov
posit
major
specimen
singl
hcov
detect
specimen
includ
sex
patient
approxim
half
hcov
detect
report
male
signific
differ
seen
sex
distribut
four
hcov
p
age
avail
specimen
singl
hcov
detect
median
patient
age
specimen
year
rang
year
patient
age
distribut
specimen
singl
hcov
detect
significantli
differ
speci
p
fig
median
age
patient
specimen
test
posit
singl
hcov
speci
follow
year
year
year
year
detect
children
year
old
fig
contrast
detect
children
year
old
fig
among
hcov
posit
detect
report
via
phlip
also
test
parainfluenza
virus
respiratori
syncyti
viru
rsv
human
metapneumoviru
human
adenoviru
rhinovirusenteroviru
influenza
influenza
b
among
report
singl
hcov
speci
detect
report
two
hcov
speci
detect
anoth
respiratori
viru
common
hcov
codetect
specimen
specimen
common
codetect
nonhcov
virus
rsv
hcov
posit
specimen
rhinovirusenteroviru
influenza
specimen
viral
speci
detect
addit
hcov
codetect
pattern
broadli
similar
among
four
hcov
tabl
report
first
describ
nation
pattern
circul
four
common
hcov
speci
unit
state
multiyear
period
studi
period
hcov
show
peak
preval
decembermarch
year
coincid
winter
respiratori
viru
season
commonli
detect
hcov
test
posit
differ
hcov
speci
predomin
differ
year
appear
peak
annual
show
variabl
distinct
peak
one
two
three
year
studi
consist
previous
publish
sitespecif
data
indic
individu
speci
may
demonstr
peak
activ
everi
year
factor
associ
annual
differ
activ
hcov
speci
current
unknown
individu
hcov
speci
activ
could
fluctuat
independ
crossimmun
within
alphacoronavirina
betacoronavirina
might
affect
annual
activ
four
hcov
studi
period
show
larg
contemporan
peak
activ
although
show
smaller
peak
activ
data
visual
censu
region
annual
season
pattern
similar
seen
nation
fig
age
distribut
patient
report
hcov
infect
differ
hcov
speci
fig
detect
common
adult
year
old
compar
previous
report
disproportion
affect
immunocompromis
individu
rel
hcov
speci
possibl
affect
median
report
age
infect
show
lowest
median
age
infect
shown
associ
croup
young
children
may
lower
averag
age
infect
nonhcov
viral
codetect
seen
specimen
posit
hcov
specimen
two
codetect
viral
speci
clinic
impact
coronavirus
codetect
fulli
understood
prior
studi
report
increas
unchang
morbid
mortal
respiratori
viral
codetect
singl
infect
hcov
associ
morbid
due
lower
upper
respiratori
tract
infect
howev
prill
et
al
demonstr
hcov
found
frequent
children
hospit
acut
respiratori
ill
andor
fever
asymptomat
control
limit
report
nrevss
passiv
voluntari
surveil
system
collect
result
specimen
submit
us
laboratori
mani
hcov
infect
subclin
mild
requir
clinic
care
therefor
infect
unlik
requir
laboratori
test
would
captur
nrevss
rel
proport
hcov
speci
report
may
repres
hcov
infect
within
nrevss
report
hcov
surveil
data
speci
level
includ
includ
inconsist
report
time
may
result
certain
laboratori
region
overrepres
certain
time
eg
winter
major
respiratori
viru
test
conduct
data
report
nrevss
phlip
repres
smaller
subset
six
laboratori
also
report
addit
data
includ
sex
age
data
report
phlip
may
repres
entir
nrevss
popul
overal
percent
hcov
posit
test
vari
phlip
nrevss
percent
hcov
posit
test
submit
nrevss
via
phlip
vs
nrevss
whole
may
result
differ
report
laboratori
report
phlip
limit
militari
state
public
health
laboratori
wherea
data
submit
directli
nrevss
nonphlip
sourc
primarili
includ
clinic
laboratori
state
local
public
health
laboratori
test
varieti
reason
includ
surveil
public
health
respons
outbreak
cluster
case
wherea
clinic
laboratori
often
test
cours
manag
individu
case
within
peak
detect
note
decembermarch
abl
defin
precis
season
onset
offset
period
individu
hcov
speci
addit
assess
hcov
percent
posit
time
base
date
submiss
report
nrevss
rather
date
specimen
collect
anticip
find
may
reflect
slight
delay
final
aggreg
data
report
nrevss
via
phlip
might
includ
multipl
specimen
patient
potenti
impact
demograph
characterist
report
case
surveil
hcov
import
determin
season
annual
circul
pattern
continu
use
respiratori
viru
multiplex
assay
panel
could
facilit
definit
hcov
circul
public
health
surveil
futur
year
data
need
better
understand
pattern
activ
hcov
studi
addit
epidemiolog
data
use
better
character
hcov
burden
spectrum
ill
find
conclus
report
author
necessarili
repres
offici
posit
us
center
diseas
control
prevent
